Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Clin Epigenetics. 2025 Jul 16;17(1):125. doi: 10.1186/s13148-025-01921-0. ABSTRACT BACKGROUND: Chronic myeloid leukemia (CML) remains a therapeutic challenge, particularly in patients who develop resistance to standard …